Integrating network pharmacology: The next-generation approach in ocular drug discovery

IF 4 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Francesca Lazzara , Federica Conti , Erika Giuffrida , Chiara Maria Eandi , Filippo Drago , Chiara Bianca Maria Platania , Claudio Bucolo
{"title":"Integrating network pharmacology: The next-generation approach in ocular drug discovery","authors":"Francesca Lazzara ,&nbsp;Federica Conti ,&nbsp;Erika Giuffrida ,&nbsp;Chiara Maria Eandi ,&nbsp;Filippo Drago ,&nbsp;Chiara Bianca Maria Platania ,&nbsp;Claudio Bucolo","doi":"10.1016/j.coph.2023.102425","DOIUrl":null,"url":null,"abstract":"<div><p>With the spread of the “omics” sciences, the approaches of systems biology can be considered as new paradigms of pharmacological research for discovery of novel targets and/or treatments for complex multifactorial diseases. Data from omics sciences can be used for the design of biologic networks, that in turn can be quantitatively analyzed to identify new pharmacological targets. In this review, we will introduce the concept of network pharmacology, particularly the application of this innovative approach in the field of ocular pharmacology, with a focus on retinal diseases such as diabetic retinopathy (DR), age-related macular degeneration (AMD) and glaucoma.</p></div>","PeriodicalId":50603,"journal":{"name":"Current Opinion in Pharmacology","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1471489223000802/pdfft?md5=337890bbaef8e8510e189b6a155a1a30&pid=1-s2.0-S1471489223000802-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1471489223000802","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

With the spread of the “omics” sciences, the approaches of systems biology can be considered as new paradigms of pharmacological research for discovery of novel targets and/or treatments for complex multifactorial diseases. Data from omics sciences can be used for the design of biologic networks, that in turn can be quantitatively analyzed to identify new pharmacological targets. In this review, we will introduce the concept of network pharmacology, particularly the application of this innovative approach in the field of ocular pharmacology, with a focus on retinal diseases such as diabetic retinopathy (DR), age-related macular degeneration (AMD) and glaucoma.

整合网络药理学:眼科药物发现的新一代方法
随着 "全方位 "科学的普及,系统生物学方法可被视为药理学研究的新范例,用于发现新的靶点和/或治疗复杂的多因素疾病。全方位科学的数据可用于生物网络的设计,而生物网络又可通过定量分析来确定新的药理靶点。在这篇综述中,我们将介绍网络药理学的概念,特别是这一创新方法在眼科药理学领域的应用,重点是糖尿病视网膜病变(DR)、老年性黄斑变性(AMD)和青光眼等视网膜疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.80
自引率
2.50%
发文量
131
审稿时长
4-8 weeks
期刊介绍: Current Opinion in Pharmacology (COPHAR) publishes authoritative, comprehensive, and systematic reviews. COPHAR helps specialists keep up to date with a clear and readable synthesis on current advances in pharmacology and drug discovery. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信